Shares of HIVE Digital Technologies Ltd. (NASDAQ:HIVE – Get Free Report) have been given a consensus recommendation of “Buy” by the nine research firms that are covering the stock, Marketbeat reports.

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) in Q4 CY2024, but sales rose 10.6% year on year to $172 ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Finds Few Reasons To Sell. In this article, we are ...